sulfurous acid bis-(1-ethyl-propyl ester)

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: sulfurous acid bis-(1-ethyl-propyl ester)
• 英文别名: Schwefligsaeure-bis-(1-aethyl-propylester)；Dipentan-3-yl sulfite；dipentan-3-yl sulfite
• 化学式: C₁₀H₂₂O₃S
• 分子量: 222.349
• InChiKey: DIICPXQOHMOTSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  14
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  54.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  3-戊醇 在 吡啶 、 氯化亚砜 、 乙醚 作用下， 生成 sulfurous acid bis-(1-ethyl-propyl ester)
  参考文献：
  名称：

  Gerrard et al., Research (London), 1955, vol. 8, p. Spl.7

  摘要：

  DOI：

文献信息

• PHOSPHONATE ANALOGS FOR TREATING METABOLIC DISEASES
  申请人：Chen James M.

  公开号：US20090131372A1

  公开（公告）日：2009-05-21

  The invention is related to phosphorus substituted compounds with activity for treating metabolic diseases and/or disorders, e.g., diabetes and hypercholesterolemia, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
• ANTIVIRAL COMPOUNDS
  申请人：Gilead Sciences, Inc.

  公开号：US20170088576A1

  公开（公告）日：2017-03-30

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
• Phosphonate analogs of HIV inhibitor compounds
  申请人：Gilead Sciences, Inc.

  公开号：US20180086784A1

  公开（公告）日：2018-03-29

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
• PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDS
  申请人：Gilead Sciences, Inc.

  公开号：US20190315785A1

  公开（公告）日：2019-10-17

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
• Gerrard et al., Research (London), 1955, vol. 8, p. Spl.7
  作者：Gerrard et al.

  DOI：——

  日期：——